Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students

Not Applicable

Completed

• Conditions: Acute Stroke

• Registration Number: NCT05462665
• Lead Sponsor: Dokuz Eylul University

Brief Summary

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Detailed Description

Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.

Study Timeline

• Study Start: 2020-05-01
• Status Verified: 2021-12
• Primary Completion: 2022-03-01
• Study Completion: 2022-03-01
• Study First Submitted: 2022-03-23
• Study First Submitted QC: 2022-07-15
• Last Update Submitted: 2022-07-15
• Study First Posted: 2022-07-18
• Last Update Posted: 2022-07-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Intern nursing student at Dokuz Eylül University

Exclusion Criteria

Those who did not agree to participate in the study Those who were not be intern

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
self-efficacy scale	Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention	Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching
simulation scale	2 weeks after simulation training	evaluation the simulation design
tPA treatment information form	Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention	Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching

Trial Locations

Locations (1)

Ozge Soydaner; 🇹🇷 İzmir, Turkey